Exosome-Based Solutions for Niche Environments and Applications

Publication ID: 24-11857575_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Exosome-Based Solutions for Niche Environments and Applications,” Published Technical Disclosure No. 24-11857575_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857575_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,575.

Summary of the Inventive Concept

The inventive concept adapts mesenchymal stem cell-derived exosomes for specialized uses in high-security environments, disaster relief, extreme weather conditions, and remote locations, ensuring targeted and effective treatment of immune-mediated inflammatory diseases.

Background and Problem Solved

The original patent disclosed the use of exosomes for treating immune-mediated inflammatory diseases. However, it did not address the specific challenges and requirements of niche environments and applications. The new inventive concept solves this problem by developing tailored solutions for these unique scenarios.

Detailed Description of the Inventive Concept

The inventive concept comprises four main aspects: (1) a secure, encrypted system for administering exosomes in high-security environments; (2) a portable, waterproof composition for disaster relief; (3) a temperature-stable formulation for extreme weather conditions; and (4) a kit with a solar-powered refrigeration unit for remote, off-grid locations. These specialized variations enable the effective treatment of immune-mediated inflammatory diseases in scenarios where conventional solutions are inadequate.

Novelty and Inventive Step

The new claims introduce novel, non-obvious features that distinguish them from the original patent. These include the use of secure, encrypted communication channels, portable and waterproof packaging, temperature-stable formulations, and solar-powered refrigeration units. These innovations provide a significant inventive step, enabling the effective treatment of immune-mediated inflammatory diseases in niche environments and applications.

Alternative Embodiments and Variations

Alternative embodiments may include using different encryption protocols, varying the composition's packaging materials, or incorporating additional features for remote monitoring and tracking. These variations can ensure broad conceptual coverage and adaptability to diverse scenarios.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of disaster relief, high-security medical services, and remote or extreme environment healthcare. Target markets may include government agencies, NGOs, and private companies operating in these niches.

Original Patent Information

Patent NumberUS 11,857,575
TitleMesenchymal stem cell-derived exosomes and their uses
Assignee(s)Ono Pharmaceutical Co., Ltd.